No activity today, make something!
afya
Statins
Markdown Help
Search globally
Save Tiddler
Revert Changes
Cancel Edit
<
> <
> beware reversible myositis (esp if hypothyroid or renal failure) SE - headache, GI, altered LFT ''inhibit action of HMG-CoA reductase'' (rate-limiting enzyme in hepatic cholesterol synthesis) ''Side effects'' //myopathy// (myalgia, myositis, rhabdomyolysis and asymptomatic raised creatine kinase) esp if older, female, low BMI, multi-system disease eg DM more with lipophilic (simva, atorva) than hydrophilic (rosuva, prava, fluva) //liver impairment// NICE 2008 - do LFT - baseline, 3 and 12/12 - stop Rx if transaminase rise //and persist// at 3x upper limit normal risk //intracerebral haemorrhage// ?inc if previous stroke - not seen in primary prevention - avoid statins in those with Hx of intracerebral haemorrhage ''Who ?'' all with established CVD (stroke, TIA, IHD, PAD) anyone with 10-year CVS risk >= 20% T2DM - previously all >40 had statin, now if >40 and any CVD risk (smoke, weight BMI, CVS score 20%) then statin) take at night (most cholesterol synthesis occurs then) - esp if simva as short half life ''Targets'' Primary - fire and forget - ie no target secondary ... ||Total cholesterol (mmol/l)|LDL cholesterol| |Joint British Societies|< 4.0|< 2.0| |National Service Framework for CHD|< 5.0|< 3.0| |SIGN 2007|< 5.0|< 3.0|
Autocomplete tags from:
Global tags
Local tags
LipidsAndStatins, CVSdrugs